EP Patent

EP3302494A1 — A freeze dried parenteral composition of tigecycline and process for preparation thereof

Assigned to Gufic Biosciences Ltd · Expires 2018-04-11 · 8y expired

What this patent protects

A stable, freeze dried pharmaceutical composition comprising Tigecycline along with sulfobutyl ether betacyclodextrin sodium as stabilizing agent for parenteral administration. The pharmaceutical composition provides stabilization of Tigecycline thereby improving the shelf life d…

USPTO Abstract

A stable, freeze dried pharmaceutical composition comprising Tigecycline along with sulfobutyl ether betacyclodextrin sodium as stabilizing agent for parenteral administration. The pharmaceutical composition provides stabilization of Tigecycline thereby improving the shelf life during storage. The invention further discloses a process of preparation of said composition.

Drugs covered by this patent

Patent Metadata

Patent number
EP3302494A1
Jurisdiction
EP
Classification
—
Expires
2018-04-11
Drug substance claim
No
Drug product claim
No
Assignee
Gufic Biosciences Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.